HRT Financial’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Buy
83,700
+68,600
+454% +$1.49M ﹤0.01% 1763
2025
Q4
$331K Buy
15,100
+1,300
+9% +$23.5K ﹤0.01% 2331
2025
Q3
$167K Buy
+13,800
New +$187K ﹤0.01% 2444
2020
Q1
Sell
-10,200
Closed -$608K 1339
2019
Q4
$608K Buy
+10,200
New +$629K 0.03% 473

Other funds holding TNDM

HRT Financial's TNDM Position: Q1 2026 in Review

HRT Financial sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 170,480 shares — an estimated $3.7M sold.

HRT Financial first reported a position in TNDM in Q3 2019 and held it in 9 quarters. The position peaked at $3.75M in Q4 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • HRT Financial reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 170,480 Tandem Diabetes Care shares in Q1 2026, an estimated $3.7M.
  • HRT Financial first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 9 quarters.
  • HRT Financial's Tandem Diabetes Care position peaked at $3.75M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.